-

Perpetuals to Participate at Upcoming Investor Conference

CEO Patrick Gruhn to Present at the Emerging Growth Conference on May 6, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Perpetuals.com Ltd (NASDAQ: PDC), the AI-powered financial services company that is leveling the playing field for traders, today announced that CEO Patrick Gruhn will present and take investor questions at the following online conference:

Emerging Growth Conference
Wednesday, May 6, 2026, at 3:40 p.m. Eastern Time

The presentation will be available via live webcast at: https://goto.webcasts.com/starthere.jsp?ei=1755070&tp_key=280dc3ffe3&sti=pdc

Questions may be submitted in advance to Questions@EmergingGrowth.com or asked during the event.

An archived replay of the conference can be seen at: https://emerginggrowth.com/

About Perpetuals

Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing AI-powered trading products and prediction markets, with a global footprint across the United States, Europe, and Asia. Its mission is to reduce risk by empowering retail users with intuitive, secure, and efficient trading experiences across multiple asset classes.

Perpetuals’s proprietary trading platform, Kronos X, combines advanced AI and data analysis. The technology is trained on billions of trades, monitors market activity in real time, identifies patterns for trading and risk decisions, and provides multi-asset coverage with self‑clearing blockchain-based settlement. The company’s licensed European Multilateral Trading Facility (MTF) infrastructure and Kronos X multi‑asset exchange platform operate with full MiFID II, MiCA, DORA, and EMIR compliance.

For more information, visit www.perpetuals.com.

Contacts

Media Contact:
press@perpetuals.com

Investor Relations:
ir@perpetuals.com

Perpetuals.com Ltd

NASDAQ:PDC

Release Versions

Contacts

Media Contact:
press@perpetuals.com

Investor Relations:
ir@perpetuals.com

More News From Perpetuals.com Ltd

Perpetuals (NASDAQ: PDC) Extends BayesShield AI Into Healthcare to Address the Root Cause of Diagnostic Errors

TOKYO--(BUSINESS WIRE)--Perpetuals.com Ltd (Nasdaq: PDC), the AI-powered financial services company, today announced the extension of its proprietary BayesShield AI technology into healthcare. BayesShield Clinical applies the same patent-pending methodology the company developed to predict trading outcomes to a new domain: identifying which physicians in hospitals and clinics are the most accurate at diagnosing specific types of cases to ensure patients get the best health outcomes. In the Unit...

Perpetuals Announces Partnership with German University of Digital Science to License AI Trading Platform

TOKYO--(BUSINESS WIRE)--Perpetuals.com Ltd (Nasdaq: PDC), a financial technology company combining trading infrastructure and artificial intelligence, today announced the execution of a strategic licensing agreement with the German University of Digital Science (German UDS) for the integration of the company’s proprietary BayesShield AI predictive intelligence platform. German UDS, a state-recognized, accredited, fully digital university based in Potsdam, Germany, will license BayesShield AI fo...
Back to Newsroom